The Journal of Organic Chemistry · 2007 · 34 citations · 25 references
PharmacyChemistryMedicinal ChemistryEnzymologyOrganic ChemistrySynthetic Medicinal ChemistryEnzyme InhibitionEnzyme-substrate RecognitionHeterocycle SynthesisHeterocyclic ChemistryOrganic SynthesisStereochemical OptimizationGamma Secretase InhibitionHeterocyclic Medicinal ChemistryHydrogenationMedicinal Heterocycles
A practical and scaleable synthesis of the gamma-secretase inhibitor 1 is reported. The inhibitor consists of a central trisubstituted cyclohexane core with appended propionic acid, 2,5-difluorophenyl, and 4-chlorophenylsulfonyl moieties. Two alternative synthetic strategies, proceeding by way of a common disubstituted cyclohexanone derivative 5, were studied. In the preferred route, conjugate reduction of acrylonitrile derivative 4 with L-Selectride configures the desired relative stereochemistry of the cyclohexane core with >99.9:0.1 dr. A second strategy, based on catalyst-controlled hydrogenation of racemic cyclohexene derivative 2, is more convergent but less diastereoselective (up to 75:25 dr). The common cyclohexanone intermediate 5 was constructed by a regioselective Diels-Alder condensation of a 1,1-disubstituted vinyl sulfone 6 with 2-trimethylsiloxybutadiene.
25
B. Lindgren, Torsten Nilsson, Steinar Husebye et al. · Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry · 1973 · 506 citations · Full text
Kazushi Mashima, Koh-hei Kusano, Naomasa Sato et al. · The Journal of Organic Chemistry · 1994 · 332 citations
Herbert C. Brown, S. Krishnamurthy · Journal of the American Chemical Society · 1972 · 292 citations